DexCom’s fair value price target has been tweaked from US$85.85 to US$86.12 per share, a small shift that still matters if you are tracking what analysts are baking into their models. This move sits ...

Venu Krishna, Barclays head of US equity strategy, joins 'Closing Bell Overtime' to talk the climb in oil prices, recent ...

Almost 20 years after the last crisis, another toxic debt bubble threatens to collide with Middle East turmoil and cause a ...

Jalen Brunson and the Knicks were a misfiring mess all night, but apparently it’s never too late to get off the struggle bus ...

The FTSE 100 extended its losses on Monday, 23 March 2026, declining 135.94 points or 1.4% to 9,782.39, marking its lowest ...

Under Armour’s fair value price target sits at US$7.73, with this latest update leaving that core estimate unchanged. Recent ...

Barclays believes that a recent pullback tied to Middle East tensions has improved the risk-reward profile for Align ...

Live Nation CEO Michael Rapino took the stand for several hours in Manhattan federal court in a high-stakes antitrust trial, ...

The prospect of stagflation is adding to central bankers’ headaches by pitting concerns over growth and inflation against ...

The US maker of French’s yellow mustard is in talks to buy Marmite and Colman’s, making them the latest British brands that ...

Consumers spend $21 trillion a year, and figuring out where that comes from helps gauge the economy’s durability in the face ...

However, for the Israeli basketball community, it was a night they’ll never forget. With Trail Blazers All-Star Deni Avdija ...